Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy

Journal of Paediatrics and Child Health

Volumn 32, Issue 3, 1996, Pages 211-217

  Kesson, A M ^a   Grimwood, K ^a,b   Burgess, M A ^a   Ferson, M J ^a   Gilbert, G L ^a   Hogg, G ^a   Isaacs, D ^a   Kakakios, A ^a   Mcintyre, P ^a  

^a Australasian Soc for Infect Dis   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

acyclovir; adolescents; children; immunocompromised; varicella; zoster immune globulin

Indexed keywords

ACICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY;

AUSTRALIA; CELLULAR IMMUNITY; CHICKENPOX; CLINICAL TRIAL; DRUG COST; EYE INFECTION; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN INFECTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PERINATAL INFECTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0030054367     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb01556.x     Document Type: Review

References (73)

1. Ferson MJ, Bell SM, Robertson PW. Determination and importance of varicella immune status of nursing staff in a children's hospital. J. Hosp. Infect. 1990; 15: 347-51.
2. Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster infections in severely immunocompromised patients. A randomised comparison of acyclovir and vidarabine. N. Engl. J. Med. 1986; 314: 208-12.
3. Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J. Infect. Dis. 1988; 157: 309-13.
4. Dunkle LM, Arvin AM, Whitley RJ et al. A controlled trial of acyclovir for chickenpox in normal children. N. Engl. J. Med. 1991; 325: 1539-44.
5. Balfour HH, Kelly JM, Suarez CS et al. Acyclovir treatment of varicella in otherwise healthy children. J. Pediatr. 1990; 116: 633-9.
6. Balfour HH, Rotbart HA, Feldman S et al. Acyclovir treatment of varicella in otherwise healthy adolescents. J. Pediatr. 1992; 120: 627-33.
7. Brunell PA. Oral acyclovir treatment of chickenpox in normal adolescents. J. Pediatr. 1992; 120: 561-2.
8. McKendrick MW. Acyclovir for childhood chickenpox. Cost is unjustified. BMJ 1995; 310: 108-9.
9. Balfour HH. Acyclovir for childhood chickenpox. No reason not to treat BMJ 1995; 310: 109-10.
10. Whitley RJ, Gnann JW. Acyclovir: A decade later. N. Engl. J. Med. 1992; 327: 782-9.
11. Biron K, Elion G. In-vitro susceptibility of varicella zoster virus to acyclovir. Antimicrob. Ag. Chemother. 1980; 18: 443-7.
12. Meszner Z, Nyerges G, Bell AR. Oral acyclovir to prevent dissemination of varicella in immunocompromised children. J. Infection 1993; 16: 9-15.
13. Arndt KA. Adverse reactions to acyclovir: topical, oral and intravenous. J. Am. Acad Derm. 1988; 18: 188-90.
14. Asano Y, Suga S, Yoshikawa T et al. Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994; 94: 524-6.
15. Ferson MJ. Another vaccine, another treadmill? J. Paediatr. Child Health 1995; 31: 3-5.
16. National Health and Medical Research Council. The Australian Immunisation Procedures Handbook, 5th edn. Australian Government Publishing Service, Canberra, 1995; 109-10.
17. Holland P, Isaacs D, Moxon ER. Fatal neonatal varicella infection. Lancet 1986; 2: 1156.
18. Feldman S, Lott L. Varicella in children with cancer: Impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80: 465-72.
19. Kirk JA, Menser MA, Bergin M, Stevens MM, De Silva LM. Varicella-zoster infection in a pediatric oncology unit. Pediatr. infect. Dis. J. 1988; 7: 520-2.
20. Balfour HH. Clinical aspects of chickenpox and herpes zoster. J.I.M.R. 1994; 22 (Suppl. 1): 3A-13A.
21. Hanngren KAJ, Falksveden L, Grandien M, Lidin-Janson G. Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients. Scand. J. Infect. Dis. 1983; 15: 327-34.
22. Jura E, Chadwick E, Josephs S et al. Varicella-zoster infections in children infected with human immunodeficiency virus. Pediatr. Infect. Dis. J. 1989; 8: 586-90.
23. Dowell S, Bresee J. Severe varicella associated with steroid use. Pediatrics 1993; 92: 1-10.
24. Feldman S. Varicella zoster infections in bone marrow transplants. In Recent Results in Cancer Research, Vol. 132. Springer-Verlag, Berlin-Heidelberg, 1993; 176-83.
25. Morgan ER. Varicella in immunocompromised children. Incidence of abdominal pain and organ involvement. Am. J. Dis. Child. 1983; 137: 883-5.
26. Prober CG, Kirk LE, Keeney R. Acyclovir therapy of chickenpox in immunosuppressed children. A collaborative study. J. Pediatr. 1982; 101: 622-5.
27. Balfour HH. Intravenous acyclovir therapy for varicella in immunocompromised children. J. Pediatr. 1984; 104: 134-6.
28. Balfour HH. Current management of varicella zoster virus infections. J. Med. Virol. 1993; (Suppl. 1): 74-81.
29. Steele RW. How should one manage a child on immunosuppression who has been exposed to chickenpox and who develops chickenpox? Pediatr. Nephrol. 1994; 8: 269.
30. Preblud SR. Varicella: Complications and costs. Pediatrics 1986; 78 (Suppl.): 728-35.
31. Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986; 78 (Suppl.): 723-7.
32. Sullivan-Bolyai JZ, Yin EK, Cox P et al. Impact of chickenpox on households of healthy children. Pediatr. Infect. Dis. J. 1987; 6: 33-5.
33. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EC. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann. Intern. Med. 1992; 117: 358-63.
34. Asano Y, Itakura N, Kajita Y et al. Severity of viremia and clinical findings in children with varicella. J. Infect. Dis. 1990; 161: 1095-8.
35. Levin MJ, Rotbart HA, Harward AR. Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella. J. Infect. Dis. 1995; 171: 1383-4.
36. Lyall EGH, Ogilvie MM, Smith NM, Burns S. Acyclovir resistant varicella zoster and HIV infection. Arch. Dis. Child. 1994; 70: 133-5.
37. Ong EL, Mulvenna P, Webb KA. Varicella-zoster infection in adults with cystic fibrosis: Role of acyclovir. Scand. J. Infect. Dis. 1991; 23: 283-5.
38. Feldman S. Acyclovir therapy for varicella in otherwise healthy children and adolescents. J. Med. Virol. 1993; (Suppl. 1): 85-9.
39. Silk HJ, Guay-Woodford L, Perez-Atayde AR, Geha RS, Broff MD. Fatal varicella in steroid-dependent asthma. J. Allergy Clin. Immunol. 1988; 81: 47-51.
40. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr. Infect. Dis. J. 1990; 9: 729-32.
41. Abzug MJ, Cotton MF. Severe chickenpox after intranasal use of corticosteroids. J. Pediatr. 1993; 123L: 577-9.
42. Kohl S. Risks of chickenpox in asthmatic child receiving inhalation steroids and therapeutic recommendations. Pediatr. Infect. Dis. J. 1993; 12: 174-5.
43. American Academy of Pediatrics Committee on Infectious Diseases. The use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 1993; 91: 674-6.
44. Reiches NA, Jones JF. Steroids and varicella. Pediatrics 1993; 92: 288-9.
45. Preblud S, Orenstein W, Bart K. Varicella: Clinical manifestations, epidemiology and health impact on children. Pediatr. Infect. Dis. J. 1984; 3: 505-9.
46. Peat JK, Toelle BG, Gray EJ et al. Prevalence and severity of childhood asthma and allergic sensitisation in seven climatic regions of New South Wales. Med J. Aust. 1995; 163: 22-6.
47. Chadwick EG. Oral acyclovir in varicella-zoster virus infections: A call for restraint. Pediatr. Dermatol. 1991; 8: 246-7.
48. Starr SE. Varicella in children receiving steroids for asthma: Risks and management. Pediatr. Infect. Dis. J. 1992; 11: 419-20.
49. Balducci I, Rodis JF, Rosengren S et al. Pregnancy outcome following first-trimester varicella infection. Obstet. Gynecol. 1992; 79: 5-6.
50. Brunell PA. Varicella in pregnancy, the fetus, and the newborn: Problems in management. J. Infect. Dis. 1992; 166 (Suppl. 1) S42-7.
51. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N. Engl. J. Med. 1986; 314: 1542-6.
52. Siegel M. Congenital malformations following chickenpox, measles, mumps, and hepatitis. JAMA 1973; 226: 1521-4.
53. Gilbert GL. Chickenpox during pregnancy. BMJ 1993; 306: 1079-80.
54. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases. Lancet 1994; 343: 1547-50.
55. Andrews EB, Yankaskas BC, Cordero JF et al. Acyclovir in pregnancy registry: Six years experience. Obstet. Gynecol. 1992; 79: 7-13.
56. Haake DA, Zokowski PC, Haake DL, Bryson YJ. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: Retro-spective controlled study and review. Rev. Infect. Dis. 1990; 12: 788-98.
57. Gershon AA. Chickenpox and zoster. In Remington JS, Klein JO eds. Infectious Diseases of the Fetus and Newborn Infant, 4th edn. WB Saunders Co., Philadelphia, 1995; 566-91.
58. McIntosh D, Isaacs D. Varicella zoster virus infection in pregnancy. Arch. Dis. Child. 1993; 68: 1-2.
59. Gilbert GL. Varicella, in Infectious Diseases in Pregnancy and the Newborn Infant. Harwood Academic Publishers, Reading, UK. 1991; 339-47.
60. Guess HA, Broughton DD, Melton LJ, Kurland LT. Epidemiology of herpes zoster in children and adolescents: A population-based study. Pediatrics 1985; 76: 512-17.
61. Wurzel CL, Kahan J, Heitler M, Rubin LG. Prognosis of herpes zoster in children. Am. J. Dis. Child. 1986; 140: 477-8.
62. Rothe MJ, Feder HM, Grant-Kels JM. Oral acyclovir therapy for varicella and zoster infections in pediatric and pregnant patients: A brief review. Pediatr. Dermatol. 1991; 8: 236-42.
63. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am. J. Med. 1988; 85 (Suppl. 2A): 79-83.
64. Novelli V, Brunell P, Geiser C et al. Herpes zoster in children with acute lymphoblastic leukaemia. Am. J. Dis. Child. 1988; 142: 71-2.
65. Balfour HH, Bean B, Laskin O et al. Acyclovir halts progression of herpes zoster in immunocompromised patients. N. Engl. J. Med. 1983; 3308: 1448-53.
66. Higa K, Dan K, Manabe H. Varicella-zoster virus infections during pregnancy: Hypothesis concerning the mechanisms of congenital malformations. Obstet. Gynecol. 1987; 69: 214-22.
67. Cobo LM, Foulks GN, Liesegang T et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93: 763-70.
68. Asano Y, Yoshikawa T, Suga S et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993; 92: 219-22.
69. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch. Dis. Child. 1993; 69: 639-43.
70. Huang Y-C, Lin T-Y, Chiu C-T. Acyclovir prophylaxis of varicella after household exposure. Pediatr. Infect. Dis. J. 1995; 14: 152-4.
71. Perren TJ, Powles RL, Easton D et al. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. Am. J. Med. 1988; 85 (Suppl. 2A): 99-101.
72. Easterbrook P, Wood MJ. Successors to acyclovir. J. Antimicrob. Chemother. 1994; 34: 307-11.
73. Safrin S, Berger TG, Gilson I et al. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella zoster virus infections. Ann. Intern. Med. 1991; 115: 19-21.